Researchers say AstraZeneca vaccine linked to Guillain-Barre syndrome
Researchers at the University College London have confirmed a rise in cases of Guillain-Barre syndrome, a potentially fatal neurological disorder, following inoculation with the AstraZeneca vaccine.